Short Interest in Health Catalyst, Inc. (NASDAQ:HCAT) Expands By 15.8%

Health Catalyst, Inc. (NASDAQ:HCAT) was the target of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 1,760,000 shares, a growth of 15.8% from the March 31st total of 1,520,000 shares. Based on an average trading volume of 616,300 shares, the days-to-cover ratio is presently 2.9 days.

Health Catalyst Trading Up 5.1 %

HCAT traded up $0.31 during midday trading on Monday, reaching $6.34. 926,109 shares of the company’s stock traded hands, compared to its average volume of 620,095. The firm has a fifty day moving average of $7.39 and a two-hundred day moving average of $8.25. Health Catalyst has a 52 week low of $5.45 and a 52 week high of $14.37. The stock has a market capitalization of $371.27 million, a price-to-earnings ratio of -3.02 and a beta of 1.29. The company has a debt-to-equity ratio of 0.62, a current ratio of 4.42 and a quick ratio of 4.42.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings data on Thursday, February 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.06. The business had revenue of $75.08 million for the quarter, compared to the consensus estimate of $73.67 million. Health Catalyst had a negative net margin of 39.92% and a negative return on equity of 12.19%. On average, equities analysts anticipate that Health Catalyst will post -0.47 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Cantor Fitzgerald reiterated an “overweight” rating and set a $16.00 target price on shares of Health Catalyst in a research report on Wednesday, April 10th. Canaccord Genuity Group reduced their target price on Health Catalyst from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Friday, February 23rd. Piper Sandler reaffirmed an “overweight” rating and set a $15.00 price target (down previously from $17.00) on shares of Health Catalyst in a research note on Friday, February 23rd. Barclays assumed coverage on Health Catalyst in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $14.00 price objective on the stock. Finally, KeyCorp restated a “sector weight” rating on shares of Health Catalyst in a research report on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, Health Catalyst presently has a consensus rating of “Moderate Buy” and an average price target of $12.10.

Institutional Investors Weigh In On Health Catalyst

Several hedge funds have recently made changes to their positions in HCAT. Los Angeles Capital Management LLC purchased a new position in Health Catalyst during the 4th quarter valued at about $108,000. Tower Research Capital LLC TRC grew its stake in shares of Health Catalyst by 285.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 12,018 shares of the company’s stock worth $111,000 after buying an additional 8,900 shares during the last quarter. Stratos Wealth Partners LTD. bought a new position in Health Catalyst during the 3rd quarter valued at approximately $114,000. MQS Management LLC purchased a new position in shares of Health Catalyst in the 3rd quarter worth about $116,000. Finally, Versor Investments LP bought a new position in Health Catalyst in the 3rd quarter valued at approximately $117,000. 85.00% of the stock is currently owned by institutional investors.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.